Cambridge Investment Research Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 44,213 shares of PPH stock, worth $3.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,213

Previous 4,828 815.76%

Holding current value

$3.92 Million

Previous $442,000 850.68%

% of portfolio

0.01%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$90.59 - $99.43 $3.57 Million - $3.92 Million	39,385 Added 815.76%	44,213 $4.2 Million
Q2 2024 Jul 26, 2024	BUY	$84.87 - $93.23 $168,127 - $184,688	1,981 Added 69.58%	4,828 $442,000
Q1 2024 Apr 24, 2024	BUY	$82.63 - $90.89 $235,247 - $258,763	2,847 New	2,847 $258,000
Q2 2023 Jul 13, 2023	BUY	$75.02 - $80.55 $242,164 - $260,015	3,228 Added 49.1%	9,802 $772,000
Q1 2023 May 11, 2023	SELL	$73.68 - $79.63 $1.47 Million - $1.59 Million	-20,019 Reduced 75.28%	6,574 $510,000
Q4 2022 Feb 08, 2023	BUY	$67.31 - $79.26 $1.57 Million - $1.85 Million	23,339 Added 717.24%	26,593 $2.07 Million
Q3 2022 Oct 17, 2022	SELL	$66.73 - $77.98 $51,181 - $59,810	-767 Reduced 19.07%	3,254 $0
Q2 2022 Jul 13, 2022	BUY	$72.65 - $83.96 $292,125 - $337,603	4,021 New	4,021 $0

Others Institutions Holding PPH

# of Institutions

147

Shares Held

5.83M

Call Options Held

12.6K

Put Options Held

7.3K

View Full List

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

More about PPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History